Numbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scores
Introduction: Osteoarthritis trials usually report average changes in visual analogue scale (VAS) pain, and examine the difference between treatment and placebo. We investigated whether dichotomous responder analysis provides a more informative interpretation of drug efficacy. Methods: Merck supplie...
| Main Authors: | , , , |
|---|---|
| 格式: | Journal article |
| 語言: | English |
| 出版: |
BioMed Central
2008
|
| 主題: |